For example, antiproliferative effects of melatonin occurred via downregulation of oncogenic factors, such as cyclin D1 in MCF-7 breast cancer cells [66] or of histone deacetylase 9 (HDAC9) in non–small cell lung cancer [67]. The gene discussed is HDAC9; the disease is breast cancer.